carisoprodol

Generic: carisoprodol

Labeler: chartwell rx, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name carisoprodol
Generic Name carisoprodol
Labeler chartwell rx, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

carisoprodol 350 mg/1

Manufacturer
Chartwell RX, LLC

Identifiers & Regulatory

Product NDC 62135-241
Product ID 62135-241_458c539a-5c3d-0ecd-e063-6294a90a2de7
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA040245
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 2019-08-08

Pharmacologic Class

Established (EPC)
muscle relaxant [epc]
Physiologic Effect
centrally-mediated muscle relaxation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62135241
Hyphenated Format 62135-241

Supplemental Identifiers

RxCUI
197446
UPC
0362135241124
UNII
21925K482H
NUI
N0000175730 N0000175737

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name carisoprodol (source: ndc)
Generic Name carisoprodol (source: ndc)
Application Number ANDA040245 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 350 mg/1
source: ndc
Packaging
  • 120 TABLET in 1 BOTTLE (62135-241-12)
source: ndc

Packages (1)

62135-241-12 120 TABLET in 1 BOTTLE (62135-241-12)

Ingredients (1)

carisoprodol (350 mg/1)

Linked Drug Pages (1)

Carisoprodol ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "458c539a-5c3d-0ecd-e063-6294a90a2de7", "openfda": {"nui": ["N0000175730", "N0000175737"], "upc": ["0362135241124"], "unii": ["21925K482H"], "rxcui": ["197446"], "spl_set_id": ["a44a3dfc-a427-4584-a086-4bc0c538b125"], "pharm_class_pe": ["Centrally-mediated Muscle Relaxation [PE]"], "pharm_class_epc": ["Muscle Relaxant [EPC]"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE (62135-241-12)", "package_ndc": "62135-241-12", "marketing_start_date": "20230105"}], "brand_name": "Carisoprodol", "product_id": "62135-241_458c539a-5c3d-0ecd-e063-6294a90a2de7", "dosage_form": "TABLET", "pharm_class": ["Centrally-mediated Muscle Relaxation [PE]", "Muscle Relaxant [EPC]"], "product_ndc": "62135-241", "dea_schedule": "CIV", "generic_name": "Carisoprodol", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Carisoprodol", "active_ingredients": [{"name": "CARISOPRODOL", "strength": "350 mg/1"}], "application_number": "ANDA040245", "marketing_category": "ANDA", "marketing_start_date": "20190808", "listing_expiration_date": "20261231"}